- GlaxoSmithKline is a British, international pharma company formed in early 2000, and was the world's sixth-largest pharma company as of 2019.
- It is the fourth largest stock on the London Stock Exchange, but holds the dubious honor of agreeing to pay the largest settlement by a drug company ever following the fraud.
- Under the hood, we have a fundamentally appealing company, but there are certain considerations that we need to be aware of before we start investing in the business.
- Because of the uncertainties here, I am choosing superior and safer investments at this time. GSK might be more interesting in the future.
For further details see:
GlaxoSmithKline - I'm Not Buying It (Yet)